Profil
Guus Scheefhals worked as Manager-Business Development at DSM Biologics Holding, Inc. from 1999 to 2003.
From 2003 to 2010, served as Chief Business Officer at Avantium Technologies BV.
From 2010 to 2025, was Chief Executive Officer at Crossbeta Biosciences BV.
From 2018 to 2020, was Chief Executive Officer at DegenRx BV.
Completed graduate studies at the University of Utrecht.
Anciens postes connus de Guus Scheefhals
| Sociétés | Poste | Fin |
|---|---|---|
Crossbeta Biosciences BV
Crossbeta Biosciences BV BiotechnologyHealth Technology Develops drug discovery programs in the area of misfolded protein diseases | Directeur Général | 01/01/2025 |
DegenRx BV
DegenRx BV BiotechnologyHealth Technology Develops gene therapies for treatment of degenerative brain dieses | Directeur Général | 01/09/2020 |
DSM Biologics Holding, Inc.
DSM Biologics Holding, Inc. BiotechnologyHealth Technology Manufactures biological and pharmaceutical products | Corporate Officer/Principal | - |
Avantium Technologies BV
Avantium Technologies BV Chemicals: SpecialtyProcess Industries Manufactures recyclable polymers | Directeur des opérations | - |
Formation de Guus Scheefhals
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Avantium Technologies BV
Avantium Technologies BV Chemicals: SpecialtyProcess Industries Manufactures recyclable polymers | Process Industries |
DSM Biologics Holding, Inc.
DSM Biologics Holding, Inc. BiotechnologyHealth Technology Manufactures biological and pharmaceutical products | Health Technology |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Crossbeta Biosciences BV
Crossbeta Biosciences BV BiotechnologyHealth Technology Develops drug discovery programs in the area of misfolded protein diseases | Health Technology |
DegenRx BV
DegenRx BV BiotechnologyHealth Technology Develops gene therapies for treatment of degenerative brain dieses | Health Technology |
















